Metabolome in urology practices: Signatures in plasma and urine

Basit Öğe Kaydı
dc.contributor.authorAsdemir, Aydemir
dc.date.accessioned2024-10-26T17:54:36Z
dc.date.available2024-10-26T17:54:36Z
dc.date.issued2023
dc.departmentSivas Cumhuriyet Üniversitesi
dc.description.abstractComparing the vast variation in biochemical processes seen in tumor cells with normal cells can be considered the initiation of metabolomics research, which is now used in different medical fields. Currently, there is an undisputed need for clinically relevant biomarkers that can be used for the diagnosis and prognosis of urologic cancer types, e.g., prostate, bladder, and metabolomics can be considered promising at this stage. Novel and relevant biomarkers are required for specialized diagnosis, monitoring, and treatment of a particular disease, which would also contribute to the improvement, enhancement, and personalization of a designed therapy. While considerable progress has been made in determining important biomarkers, more challenges remain to be solved for the further integration of metabolomics into clinical practices. This chapter reviews relevant metabolomics research conducted in the field urology. © 2023 Nova Science Publishers, Inc. All rights reserved.
dc.identifier.endpage240
dc.identifier.isbn979-889113181-1
dc.identifier.isbn979-889113095-1
dc.identifier.scopus2-s2.0-85178643892
dc.identifier.startpage225
dc.identifier.urihttps://hdl.handle.net/20.500.12418/27332
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherNova Science Publishers, Inc.
dc.relation.ispartofMetabolomics and Clinical Approach
dc.relation.publicationcategoryKitap Bölümü - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectMetabolome; Plasma; Signature; Urine; Urology
dc.titleMetabolome in urology practices: Signatures in plasma and urine
dc.typeBook Chapter

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu